John Treace - Dec 20, 2021 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Signature
/s/ Lisa Taylor as Attorney-in-fact for John T. Treace
Stock symbol
TMCI
Transactions as of
Dec 20, 2021
Transactions value $
-$966,440
Form type
4
Date filed
12/22/2021, 06:05 PM
Previous filing
Nov 24, 2021
Next filing
Dec 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale -$351K -22.3K -0.4% $15.74 5.57M Dec 20, 2021 Direct F1, F2
transaction TMCI Common Stock Sale -$9.78K -600 -0.01% $16.31 5.56M Dec 20, 2021 Direct F1, F3
transaction TMCI Common Stock Sale -$548K -34K -0.61% $16.09 5.53M Dec 21, 2021 Direct F1, F4
transaction TMCI Common Stock Sale -$57.9K -3.54K -0.06% $16.37 5.53M Dec 21, 2021 Direct F1, F5
holding TMCI Common Stock 1.61M Dec 20, 2021 By Wife F6
holding TMCI Common Stock 1.47M Dec 20, 2021 By Wife as cotrustee of the JTT Irrevocable Trust dated September 30, 2020 F6
holding TMCI Common Stock 1.84M Dec 20, 2021 As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020 F7
holding TMCI Common Stock 409K Dec 20, 2021 As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021 F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.205 to $15.935 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.24 to $16.32 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.32 to $16.31 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.32 to $16.45 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F7 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.